The Design and Optimization
of Novel Human Dihydrofolate Reductase Inhibitors for the Management of Proliferative Disease
(Sprache: Englisch)
Tetrahydrofolate, a derivative of Vitamin B9, acts a one-carbon donor during reactions necessary for the synthesis of essential nucleotide precursors. One of the enzymes which makes use of such metabolites, is Thymidylate synthesase, which is the only...
Leider schon ausverkauft
versandkostenfrei
Buch
63.90 €
Produktdetails
Produktinformationen zu „The Design and Optimization “
Klappentext zu „The Design and Optimization “
Tetrahydrofolate, a derivative of Vitamin B9, acts a one-carbon donor during reactions necessary for the synthesis of essential nucleotide precursors. One of the enzymes which makes use of such metabolites, is Thymidylate synthesase, which is the only enzyme utilising one-carbon-transfers that in the end fails to produce tetrahydrofolate. It instead produces Dihydrofolate the reduced and insufficient form of folate. The Dihydrofolate reductase enzyme (DHFR) is the enzyme that recycles the dihydrofolate to tetrahydrofolate via a redox reaction. DHFR has a crucial role in cellular proliferation, as inhibition of this ubiquitous enzyme leads to cessation of cellular growth. This makes the DHFR enzyme an ideal target in humans for inhibiting proliferation in rapidly dividing cells, with clinical sequelae in conditions such as rheumatic disease, Crohn's disease, and malignant disease.
Bibliographische Angaben
- Autor: Graziella Portelli
- 2018, 352 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 6138238567
- ISBN-13: 9786138238560
Sprache:
Englisch
Kommentar zu "The Design and Optimization"
0 Gebrauchte Artikel zu „The Design and Optimization“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "The Design and Optimization".
Kommentar verfassen